Showing results (2001-2010 of 2,073) with videos related to

Sort By:
Pageof 208
Haematologica|April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysisMatthew Mei, Raju Pillai, Soyoung Kim, et al.
Blood Advances|October 2, 2020
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeBrian C Shaffer, Kwang Woo Ahn, Zhen-Huan Hu, et al.
JAMA Oncology|December 16, 2016
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal CancerRachel Pearlman, Wendy L Frankel, Benjamin Swanson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research StudyZachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
Leukemia & Lymphoma|July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patientsBei Hu, Xiao Lin, Hans C Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2018
Global rise in emerging alien species results from increased accessibility of new source poolsHanno Seebens, Tim M Blackburn, Ellie E Dyer, et al.
Leukemia|October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survivalBrian L McClune, Kwang Woo Ahn, Hai-Lin Wang, et al.
Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Pageof 208